Stock comparison
Biogen
BIIB$29.99BHealthcare Market cap, Sector
Camurus AB (publ)
CAMX.ST$36.93BHealthcare Market cap, Sector
Overall winner
Camurus AB (publ)
BIIB 07 CAMX.ST
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
BIIB0wins
7winsCAMX.ST
45D
B78
55D
A91
35F
A94
13F
C65
26F
C63
40F
B77
41F
B77
Side-by-side metrics
| Metric | BIIB | CAMX.ST |
|---|---|---|
| Market cap | $29.99B | $36.93B Winner |
| P/E (TTM) | Winner: 21.2x | 42.6x |
| EV/EBIT | Winner: 17.3x | 29.5x |
| ROIC (TTM) | 5.44% | 17.17% Winner |
| Gross margin | 69.77% | 93.11% Winner |
| Net margin | 13.92% | 32.47% Winner |
| Revenue CAGR 5y | -2.78% | 33.3% Winner |
| EPS CAGR 5y | -4.05% | 132.79% Winner |
| Debt / Equity | 0.4x | 0.0x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BIIB leads on
- P/E (TTM)21.2xvs 42.6x+50%
- EV/EBIT17.3xvs 29.5x+42%
CAMX.ST leads on
- Revenue CAGR 5y33.3%vs -2.78%+108%
- EPS CAGR 5y132.79%vs -4.05%+103%
- Debt / Equity0.0xvs 0.4x+93%
- ROIC (TTM)17.17%vs 5.44%+68%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.